MEDIROM Healthcare Technologies (MEDIROM Healthcare Technologies) Debt-to-EBITDA : 3.36 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is MEDIROM Healthcare Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

MEDIROM Healthcare Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $8.78 Mil. MEDIROM Healthcare Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $16.57 Mil. MEDIROM Healthcare Technologies's annualized EBITDA for the quarter that ended in Dec. 2023 was $7.55 Mil. MEDIROM Healthcare Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 3.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for MEDIROM Healthcare Technologies's Debt-to-EBITDA or its related term are showing as below:

MRM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -10.11 Med: 10.21 Max: 25.54
Current: 11.94

During the past 6 years, the highest Debt-to-EBITDA Ratio of MEDIROM Healthcare Technologies was 25.54. The lowest was -10.11. And the median was 10.21.

MRM's Debt-to-EBITDA is ranked worse than
85.19% of 81 companies
in the Personal Services industry
Industry Median: 3.41 vs MRM: 11.94

MEDIROM Healthcare Technologies Debt-to-EBITDA Historical Data

The historical data trend for MEDIROM Healthcare Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDIROM Healthcare Technologies Debt-to-EBITDA Chart

MEDIROM Healthcare Technologies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

25.54

-4.65

-10.11

8.65

11.77

MEDIROM Healthcare Technologies Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial						9.70	-22.05	3.70	-7.00	3.36

Competitive Comparison of MEDIROM Healthcare Technologies's Debt-to-EBITDA

For the Personal Services subindustry, MEDIROM Healthcare Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MEDIROM Healthcare Technologies's Debt-to-EBITDA Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, MEDIROM Healthcare Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MEDIROM Healthcare Technologies's Debt-to-EBITDA falls into.

MEDIROM Healthcare Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

MEDIROM Healthcare Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(8.778	+	16.568)	/	2.154
	=	11.77

MEDIROM Healthcare Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(8.778	+	16.568)	/	7.552
	=	3.36

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

MEDIROM Healthcare Technologies (NAS:MRM) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

MEDIROM Healthcare Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MEDIROM Healthcare Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

MEDIROM Healthcare Technologies (MEDIROM Healthcare Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » MEDIROM Healthcare Technologies Inc (NAS:MRM) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-3-1 Daiba, Minato-ku, 16th Floor Tradepia Odaiba, Tokyo, JPN, 135-0091

Website

https://www.medirom.co.jp

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.